DMTs may reduce risk for becoming wheelchair dependent in patients with PPMS
JCM | Free Full-Text | Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients—The Example of Croatia
Primary progressive MS: Symptoms, diagnosis, and treatment
The Best Power Wheelchair for Multiple Sclerosis by Redman Power Chair
Primary progressive MS (PPMS): Treatment and more
Ocrevus May Delay by 7 Years PPMS Patients' Need for Wheelchair
Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials - eBioMedicine
Kaplan-Meier plot of time to first use of a wheelchair by treatment... | Download Scientific Diagram
Part I: Understanding Progression in MS | MSAA
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry - Butzkueven - 2022 - European Journal of Neurology - Wiley Online Library
The natural history of primary progressive multiple sclerosis: insights from the German NeuroTransData registry | BMC Neurology | Full Text
Ocrelizumab Reduces Wheelchair Use in Primary Progressive MS
Time to, and age at, EDSS 4.0, 6.0 and 8.0 based upon Kaplan-Meier... | Download Table
:max_bytes(150000):strip_icc()/GettyImages-946607840-04786118927148b094e830894c0caae9.jpg "Progressive-Relapsing MS: Symptoms, Causes, Treatment")
Progressive-Relapsing MS: Symptoms, Causes, Treatment
Multiple Sclerosis Patient Stories - Mitch, MS Advocate - Atara Biotherapeutics
MS Progression Chart: Stages of MS, Disability Scale, and More
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology
My Taking My Life Back Bucket List | MS And Me Media
An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability - Jerry S Wolinsky, Natalie J Engmann, Jinglan Pei, Ashish Pradhan, Clyde Markowitz, Edward J Fox,
Primary-Progressive MS: 6 Top Technology Recommendations
PPMS: Prognosis and Life Expectancy | MyMSTeam
10 Essential Facts About Primary-Progressive MS
Treatment Patterns and Unmet Need for Patients with Progressive Multiple Sclerosis in the United States: Survey Results from 2016 to 2021 | Neurology and Therapy
Blood Neurofilament Light in Progressive Multiple Sclerosis | Neurology
Blood Neurofilament Light in Progressive Multiple Sclerosis | Neurology
